Glenmark Pharmaceuticals Q3 Results
Glenmark Pharmaceuticals Q3 Results 2025:Glenmark Pharmaceuticals declared their Q3 results on 14 Feb, 2025, revealing a ...
Iterum Therapeutics faces Nasdaq non-compliance issue
Iterum Therapeutics plc (NASDAQ:ITRM), a pharmaceutical company with a market capitalization of $53.43 million, has reported a regulatory compliance issue with the Nasdaq Stock Market. According to ...
Crain's New York6h
Drugmakers step back from diversity pledges in bow to Trump
Last year, Bristol Myers Squibb devoted half a page of its annual report to its diversity, equity and inclusion efforts, ...
US gives conditional nod to Zoetis' bird flu vaccine for poultry
The U.S. Department of Agriculture has given a conditional approval to Zoetis to use its bird flu vaccine in poultry, the ...
FiercePharma7h
FDA approves Ono's rare tumor drug from $2.4B Deciphera buyout
A new FDA approval stands to give Daiichi Sankyo’s Turalio some company in a rare tumor type. | The new FDA approval gives ...
Doximity: Rating Downgrade As Near-Term Upside Is Priced In
Doximity reported strong Q3 performance, driven by high pharma client demand. Click here to find out why DOCS stock has been ...
Science Friday9h
The FDA Approves A New, Non-Opioid Painkiller
It’s the first FDA approval for a pain medication in 25 years. How does the drug work, and who is it for?
dvm3609h
Generic therapy is available for managing OA pain in horses
A new, generic, non-steroidal anti-inflammatory drug (NSAID) is now available for managing osteoarthritis (OA) pain in horses ...
GE HealthCare: Medical Imaging Giant Now Finding Its Footing to Stand Alone
Wide-moat GE HealthCare, or GEHC, is a top three global leader in the medical imaging market. It has a firmly established footprint in hospitals and health networks around the world, and it is ...